ENDRA Life Sciences Files 8-K for Regulation FD Disclosure
Ticker: NDRA · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1681682
| Field | Detail |
|---|---|
| Company | Endra Life Sciences INC. (NDRA) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
TL;DR
ENDRA Life Sciences filed an 8-K for a Reg FD disclosure on June 11, 2025.
AI Summary
ENDRA Life Sciences Inc. filed an 8-K on June 11, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself.
Why It Matters
This filing indicates ENDRA Life Sciences is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without new material financial information or significant corporate events.
Key Players & Entities
- ENDRA Life Sciences Inc. (company) — Registrant
- June 11, 2025 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Type
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure made by ENDRA Life Sciences Inc.
When was this 8-K filing submitted?
This 8-K filing was submitted on June 11, 2025.
What is the exact name of the registrant?
The exact name of the registrant is ENDRA Life Sciences Inc.
What is the principal executive office address for ENDRA Life Sciences Inc.?
The principal executive office address is 3600 Green Court, Suite 350, Ann Arbor, MI 48105.
What is the telephone number for ENDRA Life Sciences Inc.?
The telephone number for ENDRA Life Sciences Inc. is (734) 335-0468.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding ENDRA Life Sciences Inc. (NDRA).